Triple negative breast cancer (TNBC), in which cells do not have estrogen (ER-), progesterone (PR-), and HER2 (HER2-) receptors is a highly aggressive breast cancer subtype, responsible for about 20% of breast cancers. This evidence concerns the gene ERBB2 and breast carcinoma.